Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Lucid Diagnostics Inc

LUCD
Current price
1.05 USD -0.05 USD (-4.55%)
Last closed 1 USD
ISIN US54948X1090
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 51 318 696 USD
Yield for 12 month -19.23 %
1Y
3Y
5Y
10Y
15Y
LUCD
21.11.2021 - 28.11.2021

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. operates as a subsidiary of PAVmed Inc. Address: 360 Madison Avenue, New York, NY, United States, 10017

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

3.71 USD

P/E ratio

Dividend Yield

Current Year

+2 428 000 USD

Last Year

+377 000 USD

Current Quarter

+976 000 USD

Last Quarter

+1 000 999 USD

Current Year

-6 050 000 USD

Last Year

-3 237 000 USD

Current Quarter

-867 000 USD

Last Quarter

-1 156 001 USD

Key Figures LUCD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -42 581 000 USD
Operating Margin TTM -1146.72 %
PE Ratio
Return On Assets TTM -72.73 %
PEG Ratio
Return On Equity TTM -300.52 %
Wall Street Target Price 3.71 USD
Revenue TTM 3 800 000 USD
Book Value -0.75 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 513.8 %
Dividend Yield
Gross Profit TTM -3 237 000 USD
Earnings per share -1.21 USD
Diluted Eps TTM -1.21 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics LUCD

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History LUCD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation LUCD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 25.3445
Price Sales TTM 13.5049
Enterprise Value EBITDA -0.6746
Price Book MRQ 2.159

Financials LUCD

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators LUCD

For 52 weeks

0.63 USD 1.58 USD
50 Day MA 0.85 USD
Shares Short Prior Month 804 467
200 Day MA 0.93 USD
Short Ratio 6.15
Shares Short 1 087 103
Short Percent 7.61 %